Horobin Joanna

SEC source: 0001104659-26-075784 · tm2618309-3_4seq1.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,637

F1 · kind: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F2 · shares: The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant.

SEC source: 0001104659-25-081441 · tm2523977-1_4seq1.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,755

F1 · balance_after: Includes 18,396 restricted stock units granted to the Reporting Person on June 17, 2025, none of which have vested as of the date of this Form 4.

SEC source: 0001104659-25-061188 · tm2518541-3_4seq1.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,755

F1 · kind: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F2 · shares: The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant.

SEC source: 0001104659-24-074470 · tm2418154-3_4seq1.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,359

F1 · kind: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F2 · shares: The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant.

SEC source: 0000950170-24-070966 · ownership.xml · derivative · entry 4

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,195

Underlying: Common Stock · 8,500 shares

Expires 2029-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 8, 2024 adopted by the reporting person.

F4 · derivative.exercise_date: The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of May 16, 2018, subject to the reporting person's continued employment through each vesting date.

SEC source: 0000950170-24-070966 · ownership.xml · nonDerivative · entry 3

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 8, 2024 adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.88 to $33.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-070966 · ownership.xml · nonDerivative · entry 2

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,313

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 8, 2024 adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.88 to $32.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-070966 · ownership.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 8, 2024 adopted by the reporting person.

SEC source: 0001104659-23-073392 · tm2317720-6_4seq1.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-06-19

F1 · derivative.exercise_date: The option vests in 36 equal monthly installments and will become fully vested on June 19, 2026.

SEC source: 0000899243-23-015963 · doc4.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2024 and (ii) the date of the next annual meeting of the Issuer's stockholders.

SEC source: 0001493152-23-001915 · ownership.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,123

F1 · shares: On January 17, 2023, the Reporting Person was granted 7,526 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2024, so long as Reporting Person remains a director through that date.

F1 · price: On January 17, 2023, the Reporting Person was granted 7,526 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2024, so long as Reporting Person remains a director through that date.

SEC source: 0001493152-22-028718 · ownership.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,994

F1 · shares: On October 17, 2022, the Reporting Person was granted 14,285 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on October 17, 2023, so long as Reporting Person remains a director though that date.

F1 · price: On October 17, 2022, the Reporting Person was granted 14,285 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on October 17, 2023, so long as Reporting Person remains a director though that date.

SEC source: 0001493152-22-020766 · ownership.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,709

F1 · shares: On July 18, 2022, the Reporting Person was granted 8,092 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on July 18, 2023, so long as Reporting Person remains a director though that date.

F1 · price: On July 18, 2022, the Reporting Person was granted 8,092 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on July 18, 2023, so long as Reporting Person remains a director though that date.

SEC source: 0001104659-22-073532 · tm2219055-5_4seq1.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-06-17

F1 · derivative.exercise_date: The option vests in 36 equal monthly installments and will become fully vested on June 17, 2025.

SEC source: 0000899243-22-022788 · doc4.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2032-06-14

F1 · derivative.exercise_date: The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2023 and (ii) the date of the next annual meeting of the Issuer's stockholders.

SEC source: 0001493152-22-010480 · ownership.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,617

F1 · shares: On April 18, 2022, the Reporting Person was granted 6,796 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on April 18, 2023, so long as Reporting Person remains a director though that date.

F1 · price: On April 18, 2022, the Reporting Person was granted 6,796 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on April 18, 2023, so long as Reporting Person remains a director though that date.

SEC source: 0001493152-22-008835 · ownership.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,821

F1 · shares: On March 30, 2022, the Reporting Person was granted 43,478 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date.

F1 · price: On March 30, 2022, the Reporting Person was granted 43,478 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date.

SEC source: 0001493152-22-001791 · ownership.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,343

F1 · shares: On January 18, 2022, the Reporting Person was granted 5,343 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2023, so long as Reporting Person remains a director though that date.

SEC source: 0001104659-21-112110 · tm2126786-2_4seq1.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-08-20

F1 · derivative.exercise_date: The option vests in 36 equal monthly installments and will become fully vested on August 20, 2024.

SEC source: 0000899243-21-024445 · doc4.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,063

Underlying: Common Stock · 20,063 shares

Expires 2031-06-15

F1 · derivative.exercise_date: The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 16, 2022 and (ii) the date of the next annual meeting of the Issuer's stockholders.

SEC source: 0001493152-21-007816 · ownership.xml · derivative · entry 2

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,015

Underlying: Common Stock · 13,015 shares

Expires 2031-03-30

SEC source: 0001493152-21-007816 · ownership.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,068

Underlying: Common Stock · 5,068 shares

Expires 2030-12-01

F1 · kind: Pursuant to that certain Agreement and Plan of Merger, dated as of August 21, 2020, as amended, by and among Cancer Genetics, Inc. now known as Vyant Bio, Inc. ("Issuer"), CGI Acquisition, Inc., a Minnesota corporation and a wholly-owned subsidiary of Issuer ("Merger Sub") and StemoniX, Inc., a Minnesota corporation ("StemoniX") (the "Merger Agreement"), Reporting Person received options to purchase shares of Common Stock of the Issuer in exchange for options to purchase shares of StemoniX common stock, $0.0001 owned prior to the merger. These options are fully vested.

SEC source: 0001104659-21-042423 · tm2111007-2_4seq1.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,872

Underlying: Common Stock · 35,872 shares

Expires 2031-03-24

F1 · derivative.exercise_date: The option vests quarterly during 2021, with 25% of the option shares vesting on the date of grant, and 25% of the option shares vesting on each of June 30, 2021, September 30, 2021 and December 31, 2021, becoming fully vested on December 31, 2021.

SEC source: 0000899243-20-023228 · doc4.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,127

Underlying: Common Stock · 40,127 shares

Expires 2030-08-19

F1 · derivative.exercise_date: The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years commencing on the date of the Registration Statement Effectiveness.

SEC source: 0001104659-20-076074 · a4.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-06-22

F1 · derivative.exercise_date: The option vests in 36 equal monthly installments, becoming fully vested on June 22, 2023.

SEC source: 0001104659-19-049984 · a4.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2029-09-11

F1 · derivative.exercise_date: The option vests in 36 equal monthly installments, becoming fully vested on September 11, 2022.

SEC source: 0001179110-19-008596 · edgar.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,500

Underlying: Common Stock · 45,500 shares

Expires 2029-07-09

F1 · derivative.exercise_date: The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on July 9, 2019. Twenty-five percent (25%) of the stock option vests and becomes exercisable on July 9, 2020 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001179110-19-000534 · edgar.xml · derivative · entry 2

Horobin Joanna · CIK 0001560959 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,500

Underlying: Common Stock · 45,500 shares

Expires 2029-01-03

F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 3, 2019. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 3, 2020 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001179110-19-000534 · edgar.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,144

F1 · shares: Represents a restricted stock unit ("RSU") award granted under the Issuer's 2013 Stock Incentive Plan. Each RSU represents a right to receive one share of Issuer common stock. The RSU award vests over a four-year period commencing on January 3, 2019. Twenty-five percent (25%) of the shares subject to the RSU award shall vest on each one-year anniversary of the grant date of the award.

F2 · balance_after: Securities beneficially owned totaling 20,144 includes 2,044 shares of Issuer common stock owned and 18,100 of unvested RSU's held by the reporting person.

SEC source: 0001179110-18-014194 · edgar.xml · nonDerivative · entry 1

Horobin Joanna · CIK 0001560959 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,044

SEC source: 0001104659-18-052285 · a4.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 32,500 shares

Expires 2028-08-13

F1 · derivative.exercise_date: This option was granted under the Company's 2013 Stock Incentive Plan. The option vests with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in twelve equal quarterly installments following the first anniversary of the date of grant.

SEC source: 0001179110-18-000589 · edgar.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,000

Underlying: Common Stock · 270,000 shares

Expires 2028-01-03

F1 · derivative.exercise_date: This option was granted under the Company's 2013 Stock Incentive Plan. The options vest with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in twelve equal quarterly installments following the first anniversary of the date of grant.

SEC source: 0001179110-17-000644 · edgar.xml · derivative · entry 1

Horobin Joanna · CIK 0001560959 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,000

Underlying: Common Stock · 185,000 shares

Expires 2027-01-03

F1 · derivative.exercise_date: This option was granted under the Company's 2013 Stock Incentive Plan. The options vest with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in twelve equal quarterly installments following the first anniversary of the date of grant.